Two leading cardiology organizations have issued the first clinical guidelines specifically targeting cardiovascular-kidney-metabolic syndrome, a condition whose risk factors affect nearly 9 in 10 American adults. The new framework emphasizes earlier screening, lifestyle intervention, and coordinated care to head off serious complications.
The American Heart Association and the American College of Cardiology, working alongside the American Diabetes Association and the American Society of Nephrology, on June 9 published the first-ever clinical practice guidelines for cardiovascular-kidney-metabolic (CKM) syndrome — a framework that ties together three of the body’s most interconnected systems and could reshape how doctors screen and treat millions of Americans. The guidelines appear in the journals Circulation and JACC.
CKM syndrome describes the overlapping web of conditions involving the heart, kidneys and metabolic system. When one of those systems falters — say, through obesity or insulin resistance — the others are pulled along with it, elevating the risk of Type 2 diabetes, chronic kidney disease, heart attack, stroke and death. The new guidelines make explicit what researchers have long suspected: these conditions cannot be managed as though they exist in separate silos.
“Heart, kidney, and metabolic conditions don’t occur in isolation—they are deeply connected,” Chiadi E. Ndumele, chair of the guideline writing committee and the director of obesity and cardiometabolic research at Johns Hopkins School of Medicine, said in a news release. “This guideline calls for earlier screening and care, focusing on prevention and coordinated action to reduce the risk of cardiovascular disease before serious complications develop or a major cardiac event occurs.”
Why It Matters for Young People
It might be tempting to dismiss a guideline about heart and kidney disease as something meant for an older generation, but the numbers tell a different story. Roughly 90% of U.S. adults carry at least one CKM syndrome risk factor — excess weight, high blood pressure, abnormal lipid levels, elevated blood sugar, or reduced kidney function. Among children and adolescents, 21% already meet the clinical definition of obesity, a core driver of CKM progression. Poor dietary habits, sedentary behavior, chronic stress, and sleep deprivation — all hallmarks of college life — feed directly into the conditions the guideline aims to prevent.
The earlier risk is identified and addressed, the better the odds of reversing its trajectory. That urgency is baked into the guideline’s staging framework, which classifies CKM syndrome across four distinct levels, each tied to specific screening and treatment recommendations.
The Four Stages of CKM Syndrome
Stage 1 covers individuals with overweight or obesity, or prediabetes, but without additional metabolic complications, kidney disease, or cardiovascular disease. Stage 2 includes people who have developed one or more metabolic risk factors — such as Type 2 diabetes, high blood pressure, or abnormal cholesterol — and possibly early kidney disease, but still no diagnosed cardiovascular condition. Stage 3 applies to those with asymptomatic (subclinical) cardiovascular disease alongside CKM risk factors, or individuals whose 10-year cardiovascular risk is classified as high based on updated prediction tools. Stage 4 represents people already diagnosed with cardiovascular disease — including heart failure, coronary artery disease, stroke, or atrial fibrillation — who also carry metabolic or kidney-related risk factors.
Each stage is meant to guide clinicians toward appropriately timed interventions, with the explicit goal of slowing — or even reversing — disease progression before irreversible damage occurs.
Updated Risk Calculations and Social Determinants
One of the guideline’s most significant methodological advances involves replacing older cardiovascular risk calculators with the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations. Unlike previous tools, PREVENT incorporates kidney function and metabolic health markers, producing a more complete and individualized picture of a patient’s 10- and 30-year cardiovascular risk.
Equally notable is the guideline’s emphasis on screening for social determinants of health. Food insecurity, unstable housing and financial strain are now formally recognized as factors that increase CKM syndrome risk — an acknowledgment that medicine alone cannot address conditions rooted in economic inequality. For college students navigating food deserts, tight budgets and inconsistent healthcare access, this framing is particularly relevant.
Treatment Options: From Lifestyle to Surgery
The guidelines lay out a tiered treatment approach that begins with lifestyle modification and, depending on stage, scales up to medications and surgery. At the foundation is the American Heart Association’s Life’s Essential 8 framework, which covers physical activity, diet quality, body weight, blood pressure, blood sugar, cholesterol, tobacco use and sleep.
“Life’s Essential 8 focuses on regular physical activity, heart-healthy eating, maintaining a healthy weight, managing blood pressure, blood sugar and cholesterol, as well as avoiding tobacco and getting enough quality sleep. These are all powerful tools to improve cardiovascular-kidney-metabolic health,” Fátima Rodriguez, vice chair of the writing committee and an associate professor of cardiovascular medicine at Stanford Medicine, said in the news release. “These actions reduce the risk of heart disease and also support kidney and metabolic health across the lifespan.”
For patients at higher stages of CKM syndrome, medications play a central role. The guideline marks the first time GLP-1-based therapies — a class of drugs that includes widely discussed weight-loss medications — have been formally recommended for select individuals with obesity and/or Type 2 diabetes who also have elevated cardiovascular risk. SGLT2 inhibitors, another drug class with demonstrated benefits for both the heart and kidneys, are also included. Metabolic and bariatric surgery rounds out the treatment toolkit for appropriate candidates.
A Coordinated Care Model
Perhaps the guideline’s broadest implication is structural: it calls for interdisciplinary coordination among cardiologists, nephrologists, endocrinologists and primary care physicians. Historically, a patient with diabetes, early kidney disease, and high blood pressure might see three separate specialists who rarely communicate. The new guidelines push back against that fragmented model, advocating for teams that manage the full CKM picture together.
For young adults, the most actionable takeaway may be the simplest one: the conditions that lead to heart attacks and kidney failure in middle age often begin taking root in one’s 20s and 30s. The earlier those risk factors are identified and addressed, the more reversible the damage.
Source: American Heart Association